Chris Follows-Up on Ivermectin Written Answers

WA Ivermectin

Chris Follows-Up on Ivermectin Written Answers

Photo of Christopher Chope

Christopher Chope Conservative, Christchurch

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 December to Question 88624 and the Answer of 28 February 2022 to Question 127264 on Coronavirus: Ivermectin2, what the decision making process was for the Ivermectin being (a) entered into the PRINCIPLE clinical trial and (b) made the subject of monitoring by the Therapeutics Taskforce; and for what reason it an application for licensing authorisation for the use of Ivermectin in the treatment of patients with covid-19 has to be made to the MHRA before it (i)conducts a safety, efficacy and quality review and (ii) consults the Commission on Human Medicines.

Photo of Maggie Throup

Maggie Throup The Parliamentary Under-Secretary for Health and Social Care

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.

- ENDS -

Question 88624 can be viewed by CLICKING HERE

Question 127264 can be viewed by CLICKING HERE

You may also be interested in

COVID-19 Vaccine Damage (National Campaign)

Our Government is committed to keeping the public safe during the worst public health crisis of our generation. Preparing for the spread of the coronavirus outbreak is a national priority.

Parliamentary Questions

What is a Parliamentary Question?Parliamentary Questions have a significant role in the House of Commons.